Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to develop first International Standard for Influenza HA stalk based antibody to accelerating Universal flu vaccine development
Grantee
Division
Global Health
Date
MARCH 2018
Region Served
GLOBAL,
EUROPE,
NORTH AMERICA
Committed Amount
$375,710
Grant Topic
Pneumonia
Duration (Months)
22
Grantee Location
London, United Kingdom
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.